Hillman Capital
Hillman Capital Management · SEC CIK 1314620
Companies with a durable competitive advantage.
Q1 2026
Latest 13F
$144.00M
Filed US book
56
Positions
Largest holdings, as filed
Top 15 of 56 positions. Weights are against the whole filed book. 13F filings cover US-listed holdings only.
| Company | Ticker | Value | Weight |
|---|---|---|---|
| BIOGEN INC | BIIB | $5.42M | 3.8% |
| DUPONT DE NEMOURS INC | DWDPEUR | $5.40M | 3.8% |
| WARNER BROS DISCOVERY INC | WBD | $5.39M | 3.7% |
| GSK PLC | GSK | $5.38M | 3.7% |
| INTERNATIONAL FLAVORS&FRAGRA | IFF | $5.28M | 3.7% |
| PFIZER INC | PFE | $5.28M | 3.7% |
| ZIMMER BIOMET HOLDINGS INC | ZBH | $5.04M | 3.5% |
| CVS HEALTH CORP | CVS | $4.85M | 3.4% |
| BROWN FORMAN CORP | BF/B | $4.66M | 3.2% |
| CARMAX INC | KMX | $4.54M | 3.1% |
| KRAFT HEINZ CO | KHC | $4.52M | 3.1% |
| FISERV INC | FISV | $4.50M | 3.1% |
| BOEING CO | BA | $4.44M | 3.1% |
| BAXTER INTL INC | BAX | $4.15M | 2.9% |
| NIKE INC | NKE | $4.11M | 2.9% |
Inside the app: the full book for Hillman Capital Management, quarter on quarter buys and sells, consensus across 100+ funds and copy-to-watchlist.
Source: SEC EDGAR 13F filings. Values are as filed and cover US-listed positions only. Educational information, not financial advice.